A framework for quantifying the influence of adherence and dose individualization.

Item

http://www.wikidata.org/entity/Q38882371

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A framework for quantifying the influence of adherence and dose individualization.

@en

type

Item

label

A framework for quantifying the influence of adherence and dose individualization.

@en

prefLabel

A framework for quantifying the influence of adherence and dose individualization.

@en

P1476

A framework for quantifying the influence of adherence and dose individualization.

@en

P2093

P Assawasuwannakit

http://www.w3.org/2001/XMLSchema#string

R Braund

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis.

Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project).

Interventions to enhance patient adherence to medication prescriptions: scientific review.

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.

Patient adherence to prescribed antimicrobial drug dosing regimens.

Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.

Interventions to enhance medication adherence in chronic medical conditions: a systematic review.

Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.

P304

452-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPT.268

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephen B. Duffull

P577

2015-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26959756

http://www.w3.org/2001/XMLSchema#string